Important Notice
Manulife Hong Kong and Macau has been alerted to a phishing email from the address "info@manuiife-hk.site". This email contains a link and ... View more

 

We want to emphasize that this email and website are not owned, operated, or endorsed by Manulife. We take this matter very seriously and have reported it to Insurance Authority. We are coordinating with the regulatory body for further investigations. We reserve the right to take any necessary legal action.

 

If you have any doubts or believe you may have provided personal and/or credit card information to the email or website mentioned above, please contact us immediately at (852) 2108 1188 (HK) or (853) 8398 0383 (Macau), or email us at service_hk@manulife.com (HK & Macau) for assistance.

View more

Security Alert:
Stay vigilant for suspicious phone calls, emails, websites, apps and hyperlinks embedded in instant electronic messages, etc. allegedly related ... View more

View more
Skip to main content Skip to notification content
Back

Manuguard Medical Plan

The content of this website does not contain the full terms of the policy(ies), and the full terms can be found in the policy documents. The ManuGuard Medical Plan, ManuShine Healthcare Series, and ManuMaster Healthcare Series are available as basic plans or supplementary benefits.

Service(s) available through this medical insurance policy

assess your need for inpatient OGD/Colonoscopy

Provides supports by Personalized Medical Case Manager throughout the treatment journey

Your Journey, Our Support: Comprehensive Care at Every Stage

New service brings more cancer medication options

The abovementioned insurance products are provided and underwritten by Manulife (International) Limited (Incorporated in Bermuda with limited liability). The above basic product information or administrative arrangements are provided for your reference. Please download the relevant product leaflet or request it from your insurance/financial advisor, who will give you more details about the products including the ‘Important Information’ showing the product risks